Topline data were announced from a phase 3 trial evaluating orforglipron in adults with T2D and inadequate glycemic control with diet and exercise alone.

Glucagon-like peptide-1 receptor (GLP-1R) agonists have emerged as potential AUD treatment, as they have been shown to modulate reward-related behaviours, including those linked to alcohol consumption ...

A Canadian researcher has won a 2025 Breakthrough Prize in Life Sciences for discovering the GLP-1 hormone used in diabetes and obesity medications — including Ozempic, Wegovy and Mounjaro ...

Cox/Getty Images/Adam Gray/Bloomberg News/Billy Tompkins/Zuma Press Policymakers could learn a thing or two about the value of competition in healthcare from the recent shortage of GLP-1 drugs ...

WASHINGTON — States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze ...

WASHINGTON — States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that ...

The Good Bug’s Advanced Metabolic System is the latest advancement in natural GLP-1 science offering a sustainable & science-backed solution to weight loss. The breakthrough has been ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors, may be linked to a reduced risk of Alzheimer’s disease and related dementias (ADRD).